Antithrombotic strategy for non-cardiac surgery after percutaneous coronary intervention
10.3760/cma.j.issn.1008-6315.2011.12.018
- VernacularTitle:冠心病介入术后行非心脏外科手术的抗栓策略研究
- Author:
Jinggang XIA
;
Chunlin YIN
;
Yang QU
;
Hengjian HAO
;
Dong XU
- Publication Type:Journal Article
- Keywords:
Ⅱ b/Ⅲ a receptor antagonists;
Stent thrombosis;
Non-cardiac surgery;
Coronary disease
- From:
Clinical Medicine of China
2011;27(12):1276-1278
- CountryChina
- Language:Chinese
-
Abstract:
Objective To elucidate whether taking Ⅱ b/Ⅲ a receptor antagonist instead of oral antiplatelet drugs during perioperative in patients with drug-eluting stent implantation undergoing non-cardiac surgery would play a preventive role of stent thrombosis,without increasing surgical bleeding.Methods Six patients aged 60 -75 years old with drug-eluting stent implantation within 1 year taking dual antiplatelet drugs without any chest pain,and whose heart function classification for two (NYHA) were enrolled.They underwent surgical treatment due to ineffective conservative treatment of surgical disease,5 days before surgery intravenous infusion tirofiban 0.1 μg/( kg · min) micro pumps continuously instead of oral dual antiplatelet drugs,2 hours before surgery stop tirofiban and re-application of tirofiban 0.1 μg/( kg · rain) after surgery in the intensive care unit,and replacing tirofiban with oral dual antiplatelet as soon as possible according to the situation.Analyze cardiovascular events,especially stent thrombosis events and seriously bleeding,tirofiban adverse drug events during perioperative.Results Six patients have no perioperative malignant ischemic ventricular arrhythmia,angina,myocardial infarction,sudden cardiac death,no massive bleeding and adverse drug reactions.Conclusion Substitution of oral dual antiplatelet drugs for Ⅱ b/Ⅲ a receptor antagonists to prevent stent thrombosis treatment during perioperative in patients with drug-eluting stent implantation undergoing non=cardiac surgery may be feasible and safe,but needs to be further confirmed through large sample of randomly controlled trials.
